Long-term mTOR inhibitors administration evokes altered calcium homeostasis and platelet dysfunction in kidney transplant patients

The use of the mammal target of rapamycin (mTOR) inhibitors has been consolidated as the therapy of election for preventing graft rejection in kidney transplant patients, despite their immunosuppressive activity is less strong than anti-calcineurin agents like tacrolimus and cyclosporine A. Furtherm...

Descripción completa

Detalles Bibliográficos
Autores principales: López, Esther, Berna-Erro, Alejandro, Bermejo, Nuria, Brull, José María, Martinez, Rocío, Garcia Pino, Guadalupe, Alvarado, Raul, Salido, Ginés María, Rosado, Juan Antonio, Cubero, Juan José, Redondo, Pedro Cosme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822816/
https://www.ncbi.nlm.nih.gov/pubmed/23577651
http://dx.doi.org/10.1111/jcmm.12044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822816/
https://www.ncbi.nlm.nih.gov/pubmed/23577651
http://dx.doi.org/10.1111/jcmm.12044

Ejemplares similares